By Tamlin Magee
Nov. 14, 2016
One of the key outputs, Sundstrom explains, is that the offering might not be right for everyone with diabetes - but because of the completely connected nature of the platform, the group will be able to check which populations it is working for.
"We have built patient-recorded medical outcomes, and also technology-acceptance outcomes," says Sundstrom. "So at the end of the project, we will be able to see if it is working in these areas, but most critically, for whom."
"Does it work better in younger populations? Older? These are things they don't yet know around technology and self-management, and I don't think we will know until we do it. There's an assumption from the start this might be more appealing to younger people - I'm not sure that's correct. We might find older people with diabetes might take to this, we don't really know.
"I think one of the key outputs is: this isn't going to be a solution for everyone with diabetes, but identifying those populations to whom it appeals the most, and then if it doesn't appeal to certain populations, we can do what we can to adapt it so it is more appealing to those people. This is something we might do at the next stage."